Random non‐fasting C–peptide: bringing robust assessment of endogenous insulin secretion to the clinic
SV Hope, BA Knight, BM Shields… - Diabetic …, 2016 - Wiley Online Library
Background Measuring endogenous insulin secretion using C–peptide can assist diabetes
management, but standard stimulation tests are impractical for clinical use. Random non‐
fasting C–peptide assessment would allow testing when a patient is seen in clinic. Methods …
management, but standard stimulation tests are impractical for clinical use. Random non‐
fasting C–peptide assessment would allow testing when a patient is seen in clinic. Methods …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论